Clinical Study of Umbilical Cord Tissue Mesenchymal Stem Cells (UC-MSC) for Treatment of Osteoarthritis
Phase 1
Withdrawn
- Conditions
- Osteoarthritis of the Knee
- Interventions
- Biological: Human umbilical cord tissue-derived mesenchymal stem cells
- First Posted Date
- 2014-09-11
- Last Posted Date
- 2017-08-10
- Lead Sponsor
- Translational Biosciences
- Registration Number
- NCT02237846
- Locations
- π΅π¦
Stem Cell Instsitute, Panama City, Panama
Safety and Feasibility Study of Cell Therapy in Treatment of Spinal Cord Injury
Phase 1
Withdrawn
- Conditions
- Spinal Cord Injury
- Interventions
- Biological: Intravenous and intrathecal human umbilical cord tissue-derived mesenchymal stem cells and bone marrow mononuclear cells
- First Posted Date
- 2014-09-11
- Last Posted Date
- 2017-08-10
- Lead Sponsor
- Translational Biosciences
- Registration Number
- NCT02237547
- Locations
- π΅π¦
Stem Cell Institute, Panama City, Panama
Allogeneic Umbilical Cord Mesenchymal Stem Cell Therapy for Autism
Phase 1
Completed
- Conditions
- Autism
- Interventions
- Biological: Umbilical cord mesenchymal stem cells
- First Posted Date
- 2014-07-17
- Last Posted Date
- 2017-10-13
- Lead Sponsor
- Translational Biosciences
- Target Recruit Count
- 20
- Registration Number
- NCT02192749
- Locations
- π΅π¦
Stem Cell Institute, Panama City, Panama
Safety and Feasibility Study of Intranasal Mesenchymal Trophic Factor (MTF) for Treatment of Asthma
Phase 1
- Conditions
- Asthma
- Interventions
- Biological: Trophic factors from umbilical cord mesenchymal stem cells
- First Posted Date
- 2014-07-17
- Last Posted Date
- 2018-06-26
- Lead Sponsor
- Translational Biosciences
- Target Recruit Count
- 20
- Registration Number
- NCT02192736
- Locations
- π΅π¦
Punta Pacifica Hospital, Panama City, Panama
Feasibility Study of Human Umbilical Cord Tissue-Derived Mesenchymal Stem Cells in Patients With Multiple Sclerosis
Phase 1
Completed
- Conditions
- Multiple Sclerosis
- Interventions
- Biological: Umbilical cord mesenchymal stem cells
- First Posted Date
- 2014-01-13
- Last Posted Date
- 2017-08-10
- Lead Sponsor
- Translational Biosciences
- Target Recruit Count
- 20
- Registration Number
- NCT02034188
- Locations
- π΅π¦
Stem Cell Institute, Panama City, Panama
Safety and Feasibility Study of Mesenchymal Trophic Factor (MTF) for Treatment of Osteoarthritis
Phase 1
Withdrawn
- Conditions
- Osteoarthritis of the Knee
- Interventions
- Biological: Trophic factors from umbilical cord mesenchymal stem cells
- First Posted Date
- 2013-12-06
- Last Posted Date
- 2017-08-10
- Lead Sponsor
- Translational Biosciences
- Registration Number
- NCT02003131
- Locations
- π΅π¦
Stem Cell Institute, Panama City, Panama
Umbilical Cord Tissue-derived Mesenchymal Stem Cells for Rheumatoid Arthritis
Phase 1
- Conditions
- Rheumatoid Arthritis
- Interventions
- Biological: Umbilical cord mesenchymal stem cells
- First Posted Date
- 2013-11-15
- Last Posted Date
- 2019-06-20
- Lead Sponsor
- Translational Biosciences
- Target Recruit Count
- 20
- Registration Number
- NCT01985464
- Locations
- π΅π¦
Stem Cell Institute, Panama City, Panama
Autologous Adipose Tissue Stromal Vascular Fraction Cells for Rheumatoid Arthritis
Phase 1
Withdrawn
- Conditions
- Rheumatoid Arthritis
- Interventions
- Biological: Autologous stromal vascular fraction cells
- First Posted Date
- 2013-06-25
- Last Posted Date
- 2017-08-10
- Lead Sponsor
- Translational Biosciences
- Registration Number
- NCT01885819
- Locations
- π΅π¦
Stem Cell Institute, Panama City, Panama
Safety and Feasibility Study of Autologous Stromal Vascular Fraction (SVF) Cells for Treatment of Osteoarthritis
Phase 1
Withdrawn
- Conditions
- Osteoarthritis
- Interventions
- Biological: Autologous adipose tissue stromal vascular fraction
- First Posted Date
- 2013-06-25
- Last Posted Date
- 2017-08-10
- Lead Sponsor
- Translational Biosciences
- Registration Number
- NCT01885832
- Locations
- π΅π¦
Stem Cell Instsitute, Panama City, Panama
Β© Copyright 2025. All Rights Reserved by MedPath